Signatures of accelerated somatic evolution in gene promoters in multiple cancer types

Nucleic Acids Research

Volumn 43, Issue 11, 2015, Pages 5307-5317

  Smith, Kyle S ^a,b   Yadav, Vinod K ^a   Pedersen, Brent S ^a   Shaknovich, Rita ^c   Geraci, Mark W ^a,d   Pollard, Katherine S ^e   De, Subhajyoti ^a,b,d,f  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Global Health and Health Disparities   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; AMINO ACID SUBSTITUTION; ARTICLE; BASE PAIRING; CANCER CLASSIFICATION; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; COLON ADENOCARCINOMA; DNA DAMAGE; ENDOMETRIUM CARCINOMA; ESOPHAGEAL ADENOCARCINOMA; GENE IDENTIFICATION; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENOME ANALYSIS; KIDNEY CANCER; LIVER CANCER; LUNG ADENOCARCINOMA; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MATHEMATICAL MODEL; MELANOMA SKIN CANCER; ONCOGENE; ONCOGENE MYC; OVARY CANCER; OXIDATIVE STRESS; PANCREAS CANCER; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROMOTER REGION; PROTO ONCOGENE; RBM5 GENE; SIGNATURE OF ACCELERATED SOMATIC EVOLUTION MODEL; SOMATIC MUTATION; SURVIVAL TIME; THYROID CANCER; WWOX GENE; ADULT; GENE EXPRESSION; GENETICS; GENOMICS; HUMAN; MIDDLE AGED; MUTATION; NEOPLASMS; SOFTWARE;

ADULT; GENE EXPRESSION; GENOMICS; HUMANS; MIDDLE AGED; MUTATION; NEOPLASMS; PROMOTER REGIONS, GENETIC; SOFTWARE;

EID: 84936806687     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv419     Document Type: Article

References (49)

1. Lawrence, M.S., Stojanov, P., Mermel, C.H., Robinson, J.T., Garraway, L.A., Golub, T.R., Meyerson, M., Gabriel, S.B., Lander, E.S. and Getz, G. (2014) Discovery and saturation analysis of cancer genes across 21 tumour types. Nature, 505, 495-501.
2. ENCODE Project Consortium. (2012) An integrated encyclopedia of DNA elements in the human genome. Nature, 489, 57-74.
3. Huang, F.W., Hodis, E., Xu, M.J., Kryukov, G.V., Chin, L. and Garraway, L.A. (2013) Highly recurrent TERT promoter mutations in human melanoma. Science, 339, 957-959.
4. Horn, S., Figl, A., Rachakonda, P.S., Fischer, C., Sucker, A., Gast, A., Kadel, S., Moll, I., Nagore, E., Hemminki, K. et al. (2013) TERT promoter mutations in familial and sporadic melanoma. Science, 339, 959-961.
5. Aerts, S. and Cools, J. (2013) Cancer: Mutations close in on gene regulation. Nature, 499, 35-36.
6. Moran, A., Iniesta, P., de Juan, C., Garcia-Aranda, C., Diaz-Lopez, A. and Benito, M. (2005) Impairment of stromelysin-1 transcriptional activity by promoter mutations in high microsatellite instability colorectal tumors. Cancer Res., 65, 3811-3814.
7. Xu, Y., Fang, F., Ludewig, G., Jones, G. and Jones, D. (2004) A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol., 23, 527-537.
8. Xu, Y., Fang, F., Dhar, S.K., Bosch, A., St Clair, W.H., Kasarskis, E.J. and St Clair, D.K. (2008) Mutations in the SOD2 promoter reveal a molecular basis for an activating protein 2-dependent dysregulation of manganese superoxide dismutase expression in cancer cells. Mol. Cancer Res., 6, 1881-1893.
9. Killela, P.J., Reitman, Z.J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L.A. Jr, Friedman, A.H., Friedman, H., Gallia, G.L., Giovanella, B.C. et al. (2013) TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc. Natl. Acad. Sci. U.S.A., 110, 6021-6026.
10. Weinhold, N., Jacobsen, A., Schultz, N., Sander, C. and Lee, W. (2014) Genome-wide analysis of noncoding regulatory mutations in cancer. Nat. Genet., 46, 1160-1165.
11. Fredriksson, N.J., Ny, L., Nilsson, J.A. and Larsson, E. (2014) Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types. Nat. Genet., 46, 1258-1263.
12. Muller, P.A. and Vousden, K.H. (2013) p53 mutations in cancer. Nat. Cell Biol., 15, 2-8.
13. Pollard, K.S., Salama, S.R., Lambert, N., Lambot, M.A., Coppens, S., Pedersen, J.S., Katzman, S., King, B., Onodera, C., Siepel, A. et al. (2006) An RNA gene expressed during cortical development evolved rapidly in humans. Nature, 443, 167-172.
14. Ziegeler, M., Cevec, M., Richter, C. and Schwalbe, H. (2012) NMR studies of HAR1 RNA secondary structures reveal conformational dynamics in the human RNA. Chembiochem, 13, 2100-2112.
15. Pollard, K.S., Salama, S.R., King, B., Kern, A.D., Dreszer, T., Katzman, S., Siepel, A., Pedersen, J.S., Bejerano, G., Baertsch, R. et al. (2006) Forces shaping the fastest evolving regions in the human genome. PLoS Genet., 2, e168.
16. International Cancer Genome Consortium., Hudson, T.J., Anderson, W., Artez, A., Barker, A.D., Bell, C., Bernabe, R.R., Bhan, M.K., Calvo, F., Eerola, I. et al. (2010) International network of cancer genome projects. Nature, 464, 993-998.
17. Cancer Genome Atlas Research Network. (2014) Comprehensive molecular profiling of lung adenocarcinoma. Nature, 511, 543-550.
18. Berger, M.F., Hodis, E., Heffernan, T.P., Deribe, Y.L., Lawrence, M.S., Protopopov, A., Ivanova, E., Watson, I.R., Nickerson, E., Ghosh, P. et al. (2012) Melanoma genome sequencing reveals frequent PREX2 mutations. Nature, 485, 502-506.
19. Morin, R.D., Mungall, K., Pleasance, E., Mungall, A.J., Goya, R., Huff, R.D., Scott, D.W., Ding, J., Roth, A., Chiu, R. et al. (2013) Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. Blood, 122, 1256-1265.
20. Liu, L., De, S. and Michor, F. (2013) DNA replication timing and higher-order nuclear organization determine single-nucleotide substitution patterns in cancer genomes. Nat. Commun., 4, 1502.
21. Schuster-Bockler, B. and Lehner, B. (2012) Chromatin organization is a major influence on regional mutation rates in human cancer cells. Nature, 488, 504-507.
22. De, S., Pedersen, B.S. and Kechris, K. (2014) The dilemma of choosing the ideal permutation strategy while estimating statistical significance of genome-wide enrichment. Brief. Bioinform., 15, 919-928.
23. Bickel, P.J., Boley, N., Brown, J.B., Huang, H. and Zhang, N.R. (2010) Subsampling methods for genomic inference. Ann. Appl. Stat., 4, 1660-1697.
24. Alexandrov, L.B., Nik-Zainal, S., Wedge, D.C., Aparicio, S.A., Behjati, S., Biankin, A.V., Bignell, G.R., Bolli, N., Borg, A., Borresen-Dale, A.L. et al. (2013) Signatures of mutational processes in human cancer. Nature, 500, 415-421.
25. Davydov, E.V., Goode, D.L., Sirota, M., Cooper, G.M., Sidow, A. and Batzoglou, S. (2010) Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput. Biol., 6, e1001025.
26. Lawrence, M.S., Stojanov, P., Polak, P., Kryukov, G.V., Cibulskis, K., Sivachenko, A., Carter, S.L., Stewart, C., Mermel, C.H., Roberts, S.A. et al. (2013) Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature, 499, 214-218.
27. Woo, Y.H. and Li, W.H. (2012) DNA replication timing and selection shape the landscape of nucleotide variation in cancer genomes. Nat. Commun., 3, 1004.
28. Aukema, S.M., Siebert, R., Schuuring, E., van Imhoff, G.W., Kluin-Nelemans, H.C., Boerma, E.J. and Kluin, P.M. (2011) Double-hit B-cell lymphomas. Blood, 117, 2319-2331.
29. Morel, A.P., Sentis, S., Bianchin, C., Le Romancer, M., Jonard, L., Rostan, M.C., Rimokh, R. and Corbo, L. (2003) BTG2 antiproliferative protein interacts with the human CCR4 complex existing in vivo in three cell-cycle-regulated forms. J. Cell Sci., 116, 2929-2936.
30. Wagener, N., Bulkescher, J., Macher-Goeppinger, S., Karapanagiotou-Schenkel, I., Hatiboglu, G., Abdel-Rahim, M., Abol-Enein, H., Ghoneim, M.A., Bastian, P.J., Muller, S.C. et al. (2013) Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients. Br. J. Cancer, 108, 973-982.
31. Pekarsky, Y., Hallas, C. and Croce, C.M. (2001) The role of TCL1 in human T-cell leukemia. Oncogene, 20, 5638-5643.
32. Yamane, A., Resch, W., Kuo, N., Kuchen, S., Li, Z., Sun, H.W., Robbiani, D.F., McBride, K., Nussenzweig, M.C. and Casellas, R. (2011) Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes. Nat. Immunol., 12, 62-69.
33. Dominguez, P.M. and Shaknovich, R. (2014) Epigenetic function of activation-induced cytidine deaminase and its link to lymphomagenesis. Front. Immunol., 5, 642.
34. Pasqualucci, L., Neumeister, P., Goossens, T., Nanjangud, G., Chaganti, R.S., Kuppers, R. and Dalla-Favera, R. (2001) Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature, 412, 341-346.
35. Zhao, L., Li, R., Shao, C., Li, P., Liu, J. and Wang, K. (2012) 3p21.3 tumor suppressor gene RBM5 inhibits growth of human prostate cancer PC-3 cells through apoptosis. World J. Surg. Oncol., 10, 247.
36. Sutherland, L.C., Wang, K. and Robinson, A.G. (2010) RBM5 as a putative tumor suppressor gene for lung cancer. J. Thorac. Oncol., 5, 294-298.
37. Avvakumov, N., Lalonde, M.E., Saksouk, N., Paquet, E., Glass, K.C., Landry, A.J., Doyon, Y., Cayrou, C., Robitaille, G.A., Richard, D.E. et al. (2012) Conserved molecular interactions within the HBO1 acetyltransferase complexes regulate cell proliferation. Mol. Cell. Biol., 32, 689-703.
38. Nicolson, G.L., Nawa, A., Toh, Y., Taniguchi, S., Nishimori, K. and Moustafa, A. (2003) Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation. Clin. Exp.Metastasis, 20, 19-24.
39. Qian, H., Yu, J., Li, Y., Wang, H., Song, C., Zhang, X., Liang, X., Fu, M. and Lin, C. (2007) RNA interference of metastasis-associated gene 1 inhibits metastasis of B16F10 melanoma cells in a C57BL/6 mouse model. Biol. Cell, 99, 573-581.
40. Ono, T., Losada, A., Hirano, M., Myers, M.P., Neuwald, A.F. and Hirano, T. (2003) Differential contributions of condensin I and condensin II to mitotic chromosome architecture in vertebrate cells. Cell, 115, 109-121.
41. Lapointe, J., Malhotra, S., Higgins, J.P., Bair, E., Thompson, M., Salari, K., Giacomini, C.P., Ferrari, M., Montgomery, K., Tibshirani, R. et al. (2008) hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature. Am. J. Surg. Pathol., 32, 205-209.
42. Kino, K. and Sugiyama, H. (2005) UVR-induced G-C to C-G transversions from oxidative DNA damage. Mutat. Res., 571, 33-42.
43. Kino, K. and Sugiyama, H. (2001) Possible cause of G-C-C-G transversion mutation by guanine oxidation product, imidazolone. Chem. Biol., 8, 369-378.
44. Verma, A., Yadav, V.K., Basundra, R., Kumar, A. and Chowdhury, S. (2009) Evidence of genome-wide G4 DNA-mediated gene expression in human cancer cells. Nucleic Acids Res., 37, 4194-4204.
45. Bruno, A., Boisselier, B., Labreche, K., Marie, Y., Polivka, M., Jouvet, A., Adam, C., Figarella-Branger, D., Miquel, C., Eimer, S. et al. (2014) Mutational analysis of primary central nervous system lymphoma. Oncotarget, 5, 5065-5075.
46. Morin, R.D. and Gascoyne, R.D. (2013) Newly identified mechanisms in B-cell non-Hodgkin lymphomas uncovered by next-generation sequencing. Semin. Hematol., 50, 303-313.
47. Kemp, C.J., Moore, J.M., Moser, R., Bernard, B., Teater, M., Smith, L.E., Rabaia, N.A., Gurley, K.E., Guinney, J., Busch, S.E. et al. (2014) CTCF haploinsufficiency destabilizes DNA methylation and predisposes to cancer. Cell Rep., 7, 1020-1029.
48. Mansour, M.R., Abraham, B.J., Anders, L., Berezovskaya, A., Gutierrez, A., Durbin, A.D., Etchin, J., Lawton, L., Sallan, S.E., Silverman, L.B. et al. (2014) Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science, 346, 1373-1377.
49. Chisholm, K.M., Bangs, C.D., Bacchi, C.E., Kirsch, H.M., Cherry, A. and Natkunam, Y. (2015) Expression profiles of MYC protein and MYC gene rearrangement in lymphomas. Am. J. Surg. Pathol., 39, 294-303.